Drugmaker Mundipharma International Ltd，owned by the billionaire American Sackler family, has kicked off the sale of its China unit in a deal that could fetch more than $1 billion, people familiar with the situation told Reuters.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
